Tablets
Oral solid dosage tablets produced through controlled, reproducible processes.
3.165 bn units / year
A portfolio built around healthcare needs.
Portfolio
Grandene's product portfolio will be developed in line with approved manufacturing capabilities, regulatory requirements and healthcare needs. Our focus is on building a responsible portfolio supported by quality manufacturing and reliable supply.
Oral solid dosage tablets produced through controlled, reproducible processes.
3.165 bn units / year
Hard capsules designed for accurate, consistent oral dosing.
369 mn units / year
Powders and granules in single-dose sachets for convenient administration.
18 mn units / year
Moisture-sensitive effervescent tablets requiring tightly controlled environments.
Soft capsules for liquid and semi-solid formulations.
180 mn units / year
Semi-solid topical preparations for dermatological use.
9 mn units / year
Suppositories manufactured with precise moulding and temperature control.
30 mn units / year
Our product listings will be published here once registrations are approved. Each product will include therapeutic area, molecule name, dosage form and strength, pack presentation and market registration status.
We believe strong pharmaceutical manufacturing is built through collaboration. Grandene welcomes engagement with pharmaceutical companies, technology owners, formulation partners, equipment specialists and quality experts for technology transfer, localization and long-term manufacturing partnerships.